Dinesh Nair
December 12, 2022 | Daily Business Review
Dealmakers in Last-Minute $70B M&A Rush Before HolidaysBiotech giant Amgen is leading the flurry of transactions, saying it will buy Horizon Therapeutics for $28 billion to add drugs for rare disorders.
By Ben Scent and Dinesh Nair
3 minute read
December 06, 2022 | Daily Business Review
Blue Chips Front Money for Buyers of Their Unwanted AssetsDealmakers are dusting off their playbooks from the global financial crisis, devising creative ways to get transactions completed as traditional financing sources dry up.
By Dinesh Nair
3 minute read
Trending Stories
- 1New York-Based Skadden Team Joins White & Case Group in Mexico City for Citigroup Demerger
- 2No Two Wildfires Alike: Lawyers Take Different Legal Strategies in California
- 3Poop-Themed Dog Toy OK as Parody, but Still Tarnished Jack Daniel’s Brand, Court Says
- 4Meet the New President of NY's Association of Trial Court Jurists
- 5Lawyers' Phones Are Ringing: What Should Employers Do If ICE Raids Their Business?
